# A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

> **NCT01970124** · PHASE3 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.**

## Conditions studied

- Spinocerebellar Degeneration

## Interventions

- **DRUG:** KPS-0373, High dose
- **DRUG:** KPS-0373, Low dose

## Key facts

- **NCT ID:** NCT01970124
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2015-05
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2016-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01970124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01970124, "A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01970124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*